[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.146.179.146. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Commentary
December 2001

Sudden Cardiac Death and Antipsychotic DrugsDo We Know Enough?

Arch Gen Psychiatry. 2001;58(12):1168-1171. doi:10.1001/archpsyc.58.12.1168

ANTIPSYCHOTIC drugs have revolutionized the treatment of psychotic and mood disorders since their introduction 50 years ago. Although psychiatric patients have significantly benefited from the use of typical antipsychotic drugs, their limitations have become apparent and include extrapyramidal symptoms and tardive dyskinesia. The next generation of antipsychotic drugs (novel or atypical) offers advantages compared with the typical antipsychotic drugs: they are uniformly better tolerated and are more efficacious in certain symptom domains. However, current data do not suggest that these new medications offer advantages regarding cardiovascular adverse effects.1

First Page Preview View Large
First page PDF preview
First page PDF preview
×